in MagnetisMM-5 as a therapy for relapsed/refractory multiple myeloma in patients previously treated with lenalidomide and a proteasome inhibitor. Among the new phase 3 starts are CDK4 inhibitor ...

ABSTRACT: In traditional medicine, the decoction of Ximenia americana bark is employed for the treatment of various ailments; however, there has been a paucity of research evaluating its ...

University of Missouri - Columbia, Columbia, MO.

Department of Pharmaceutical Sciences, University of California, Irvine, California 92617, United States ...